Skip to main content
. Author manuscript; available in PMC: 2011 Sep 23.
Published in final edited form as: For Immunopathol Dis Therap. 2010 Jul 1;1(3):205–218. doi: 10.1615/ForumImmunDisTher.v1.i3.30

FIGURE 4.

FIGURE 4

Selective inhibitory activity of JS-K against a panel of renal cancer cell lines (TK-10, 786-O, and UO-30) compared with the normal renal epithelial cell line HREpC. (Adapted from Chakrapani et al., 2008.9)